SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-May-24 8:14 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Option Exercise | 2,656 | -- | -- | 2% 120.58K to 123.23K | |
17-May-24 8:14 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-May-24 | Planned Option Sale | 843 | $0.94 | $792.42 | (< 1%) 123.23K to 122.39K | |
16-Feb-24 9:48 PM View: | Seres Therapeutics, Inc. (MCRB) | 16-Feb-24 | Planned Option Sale | 3,939 | $1.08 | $4,254.12 | (3%) 124.52K to 120.58K | |
16-Feb-24 9:48 PM View: | Seres Therapeutics, Inc. (MCRB) | 15-Feb-24 | Option Exercise | 10,625 | -- | -- | 9% 113.89K to 124.52K | |
31-Oct-23 9:39 PM View: | Seres Therapeutics, Inc. (MCRB) | 30-Oct-23 | Planned Option Sale | 4,156 | $1.35 | $5,610.60 | (4%) 118.05K to 113.89K | |
31-Oct-23 9:39 PM View: | Seres Therapeutics, Inc. (MCRB) | 27-Oct-23 | Option Exercise | 13,501 | -- | -- | 13% 104.55K to 118.05K | |
06-Jul-22 7:29 PM View: | Seres Therapeutics, Inc. (MCRB) | 05-Jul-22 | Grant | 63,492 | $3.15 | $200,000.00 | 155% 41.05K to 104.55K | |
28-Jan-20 4:06 PM View: | Seres Therapeutics, Inc. (MCRB) | 26-Jan-20 | Option Exercise | 25,000 | -- | -- | 156% 16.05K to 41.05K | |
29-Jan-19 6:55 PM View: | Seres Therapeutics, Inc. (MCRB) | 28-Jan-19 | Market Option Sale | 5,471 | $5.75 | $31,477.90 | (25%) 21.52K to 16.05K | (269%) |
29-Jan-19 6:55 PM View: | Seres Therapeutics, Inc. (MCRB) | 26-Jan-19 | Option Exercise | 15,000 | -- | -- | 230% 6.53K to 21.52K | |
30-Jan-18 8:58 PM View: | Seres Therapeutics, Inc. (MCRB) | 26-Jan-18 | Option Exercise | 10,000 | -- | -- | 100% 0 to 10.0K | |
30-Jan-18 8:58 PM View: | Seres Therapeutics, Inc. (MCRB) | 26-Jan-18 | Market Option Sale | 3,475 | $11.02 | $38,294.50 | (35%) 10.0K to 6.53K | (93%) |
30-Mar-16 5:04 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 18-Feb-16 | Payment of Exercise | 18,370 | $5.03 | $92,401.10 | (33%) 55.0K to 36.63K | (373%) |
30-Mar-16 5:04 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 18-Feb-16 | Option Exercise | 55,000 | -- | -- | 100% 0 to 55.0K | |
21-Jan-15 5:07 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 21-Jan-15 | Disposition (other) | 7,967 | $102.00 | $812,634.00 | (94%) 8.45K to 0.48K | < 1% |
21-Jan-15 5:07 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 21-Jan-15 | Disposition (other) | 479 | $102.00 | $48,858.00 | (100%) 0.48K to 0 | < 1% |
02-Jan-14 3:36 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 31-Dec-14 | Acquisition (other) | 278 | $42.59 | $11,841.00 | 108% 0.26K to 0.54K | |
05-Jan-15 4:03 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 31-Dec-14 | Acquisition (other) | 148 | $59.96 | $8,873.93 | 2% 8.3K to 8.45K | |
31-Dec-14 4:04 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 29-Dec-14 | Payment of Exercise | 11,978 | $100.71 | $1,206,300.00 | (59%) 20.28K to 8.3K | (< 1%) |
31-Dec-14 4:04 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 29-Dec-14 | Option Exercise | 17,975 | $45.90 | $825,052.00 | 781% 2.3K to 20.28K | |
02-Oct-14 4:01 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 30-Sep-14 | Acquisition (other) | 48 | $66.34 | $3,184.32 | 2% 2.25K to 2.3K | 53% |
02-Jul-14 4:17 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 30-Jun-14 | Acquisition (other) | 213 | $57.87 | $12,325.90 | 11% 1.95K to 2.16K | |
02-Jul-14 4:17 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 30-Jun-14 | Acquisition (other) | 89 | $69.82 | $6,213.98 | 4% 2.16K to 2.25K | 45% |
16-Apr-14 4:44 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 16-Apr-14 | Market Option Sale | 768 | $64.00 | $49,152.10 | (28%) 2.72K to 1.95K | (58%) |
16-Apr-14 4:44 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 15-Apr-14 | Option Exercise | 2,377 | -- | -- | 695% 0.34K to 2.72K | |
02-Apr-14 4:11 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 31-Mar-14 | Acquisition (other) | 84 | $73.15 | $6,144.60 | 33% 0.26K to 0.34K | 38% |
02-Jan-14 3:36 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 31-Dec-13 | Acquisition (other) | 67 | $68.87 | $4,614.29 | 35% 0.19K to 0.26K | 47% |
02-Oct-13 2:59 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 30-Sep-13 | Acquisition (other) | 93 | $63.55 | $5,910.15 | 95% 98 to 0.19K | 59% |
02-Jul-13 2:39 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 28-Jun-13 | Acquisition (other) | 98 | $48.29 | $4,732.42 | 100% 0 to 98 | 110% |
06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 11,375 | $74.00 | $841,750.00 | (48%) 23.62K to 12.24K | (3%) |
06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 11,375 | -- | -- | 93% 12.24K to 23.62K | |
06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 5,738 | $74.00 | $424,612.00 | (47%) 12.24K to 6.5K | (3%) |
06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 6,505 | $74.00 | $481,370.00 | (100%) 6.5K to 0 | (3%) |
26-May-10 3:14 PM View: | Genzyme Corp. (GENZ) | 25-May-10 | Market Option Sale | 1,972 | $45.60 | $89,923.20 | (15%) 13.29K to 11.32K | (12%) |
26-May-10 3:14 PM View: | Genzyme Corp. (GENZ) | 24-May-10 | Option Exercise | 5,833 | -- | -- | 78% 7.46K to 13.29K | |
29-Apr-09 1:57 PM View: | Genzyme Corp. (GENZ) | 23-Apr-09 | Acquisition | 3,772 | $52.10 | $196,514.00 | 151% 2.5K to 6.27K | 1% |
08-Aug-08 2:20 PM View: | Genzyme Corp. (GENZ) | 07-Aug-08 | Option Exercise | 10,725 | -- | -- | 472% 2.27K to 13.0K | |
08-Aug-08 2:20 PM View: | Genzyme Corp. (GENZ) | 07-Aug-08 | Market Option Sale | 10,725 | $78.99 | $847,168.00 | (83%) 13.0K to 2.27K | 33% |